RG REGENESYS BVBA Trademark

Trademark Overview

On Tuesday, September 9, 2014, a trademark application was filed for RG REGENESYS BVBA with the United States Patent and Trademark Office. The USPTO has given the RG REGENESYS BVBA trademark a serial number of 86389705. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 11, 2022. This trademark is owned by ABT Holding Company. The RG REGENESYS BVBA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

clinical and scientific research directed to developing cells having genetic characteristics that are useful in the development of therapeutic and diagnostic compounds; clinical and scientific research directed to the development of compounds for therapy and diagnosis; and clinical and scientific research directed to the discovery of medically relevant genes
rg regenesys bvba

General Information

Serial Number86389705
Word MarkRG REGENESYS BVBA
Filing DateTuesday, September 9, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 11, 2022
Registration Number4839632
Registration DateTuesday, October 27, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 11, 2015

Trademark Statements

Description of MarkThe mark consists of capital "R" letter above and behind capital "G" letter overlapping and angled down from "R" letter in a box with curved angles next to the text "REGENESYS" centered from angled box in all capital letters with the capital letters "BVBA" to the right side below the "Y" and "S" capital letters.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BVBA"
Goods and Servicesclinical and scientific research directed to developing cells having genetic characteristics that are useful in the development of therapeutic and diagnostic compounds; clinical and scientific research directed to the development of compounds for therapy and diagnosis; and clinical and scientific research directed to the discovery of medically relevant genes

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 17, 2014
Primary Code042
First Use Anywhere DateWednesday, August 1, 2007
First Use In Commerce DateWednesday, August 1, 2007

Trademark Owner History

Party NameABT Holding Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCleveland, OH 44115
Party NameABT Holding Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCleveland, OH 44114
Party NameABT Holding Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCleveland, OH 44114

Trademark Events

Event DateEvent Description
Wednesday, September 17, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 18, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, December 19, 2014ASSIGNED TO EXAMINER
Wednesday, December 24, 2014NON-FINAL ACTION WRITTEN
Wednesday, December 24, 2014NON-FINAL ACTION E-MAILED
Wednesday, December 24, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 18, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 25, 2015ASSIGNED TO LIE
Thursday, July 2, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 2, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 2, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 11, 2015PUBLISHED FOR OPPOSITION
Tuesday, August 11, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, October 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 8, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 12, 2014NEW APPLICATION ENTERED
Thursday, October 8, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 27, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 11, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 11, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 5, 2021TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 11, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, October 28, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

bvba regenesys clinical research directed scientific development compounds therapy diagnosis relevant genes